Biosino Bio-Technology and Science (HKSE:08247) Days Sales Outstanding : 207.82 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science Days Sales Outstanding?

Biosino Bio-Technology and Science's average Accounts Receivable for the three months ended in Dec. 2023 was HK$195.6 Mil. Biosino Bio-Technology and Science's Revenue for the three months ended in Dec. 2023 was HK$85.9 Mil. Hence, Biosino Bio-Technology and Science's Days Sales Outstanding for the three months ended in Dec. 2023 was 207.82.

The historical rank and industry rank for Biosino Bio-Technology and Science's Days Sales Outstanding or its related term are showing as below:

HKSE:08247' s Days Sales Outstanding Range Over the Past 10 Years
Min: 85.8 Med: 165.98 Max: 251.79
Current: 250.99

During the past 13 years, Biosino Bio-Technology and Science's highest Days Sales Outstanding was 251.79. The lowest was 85.80. And the median was 165.98.

HKSE:08247's Days Sales Outstanding is ranked worse than
88.48% of 217 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.88 vs HKSE:08247: 250.99

Biosino Bio-Technology and Science's Days Sales Outstanding increased from Dec. 2022 (201.88) to Dec. 2023 (207.82).

Biosino Bio-Technology and Science Days Sales Outstanding Historical Data

The historical data trend for Biosino Bio-Technology and Science's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science Days Sales Outstanding Chart

Biosino Bio-Technology and Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

168.32

231.66

212.52

216.69

251.79

Biosino Bio-Technology and Science Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															201.88	271.17	269.19	261.51	207.82

Competitive Comparison of Biosino Bio-Technology and Science's Days Sales Outstanding

For the Diagnostics & Research subindustry, Biosino Bio-Technology and Science's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosino Bio-Technology and Science's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biosino Bio-Technology and Science's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Biosino Bio-Technology and Science's Days Sales Outstanding falls into.

Biosino Bio-Technology and Science Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Biosino Bio-Technology and Science's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (240.664	+	195.565)	/	2 )	/	316.182	*	365
=	218.1145					/	316.182	*	365
=	251.79

Biosino Bio-Technology and Science's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	195.565)	/	1 )	/	85.871	*	365 / 4
=	195.565					/	85.871	*	365 / 4
=	207.82

Biosino Bio-Technology and Science (HKSE:08247) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Biosino Bio-Technology and Science Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosino Bio-Technology and Science (HKSE:08247) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200

Website

http://www.zhongsheng.com.cn

Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.

Executives

Beijing Enterprises Group Company Limited	2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited	2101 Beneficial owner
Hk Zhixin Investment Co., Ltd.	2101 Beneficial owner
Li Dongfeng	2201 Interest of corporation controlled by you
Yan Kang	2201 Interest of corporation controlled by you
Qiu Zhe Feng	2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Li Yang Yi Xiong	2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines